Progressive neuronal degeneration in brain regions involved in learning and
memory processes is a common occurrence in patients infected with human im
munodeficiency virus type 1 (HIV-1). We now report that levels of Par-4, a
protein recently linked to neuronal apoptosis in Alzheimer's disease, are i
ncreased in neurons in hippocampus of human patients with HIV encephalitis
and in monkeys infected with a chimeric strain of HIV-1 and simian immunode
ficiency virus. Par-4 levels Increased rapidly in cultured hippocampal neur
ons following exposure to the neurotoxic HIV-1 protein Tat, and treatment o
f the cultures with a Par-4 antisense oligonucleotide protected the neurons
against Tat-induced apoptosis, Additional findings show that Par-4 partici
pates at an early stage of Tat-induced neuronal apoptosis before caspase ac
tivation, oxidative stress, and mitochondrial dysfunction. Our data suggest
that Par-4 may be a mediator of neuronal apoptosis in HIV encephalitis and
that therapeutic approaches targeting the Par-4 apoptotic cascade may prov
e beneficial in preventing neuronal degeneration and associated dementia in
patients infected with HIV-1.